Marston William A, Davies Stephen W, Armstrong Brian, Farber Mark A, Mendes Robert C, Fulton Joseph J, Keagy Blair A
Division of Vascular Surgery, Department of Surgery, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7212, USA.
J Vasc Surg. 2006 Jul;44(1):108-114. doi: 10.1016/j.jvs.2006.03.026.
The natural history of limbs affected by ischemic ulceration is poorly understood. In this report, we describe the outcome of limbs with stable chronic leg ulcers and arterial insufficiency that were treated with wound-healing techniques in patients who were not candidates for revascularization.
A prospectively maintained database of limb ulcers treated at a comprehensive wound center was used to identify patients with arterial insufficiency, defined as an ankle-brachial index (ABI) <0.7 or a toe pressure <50 mm Hg. Patients were treated without revascularization when medical comorbidity or anatomic considerations did not allow revascularization with acceptable risk. Ulcers were treated with a protocol emphasizing pressure relief, débridement, infection control, and moist wound healing. Risk factors analyzed for their affect on healing and amputation risk included age, gender, diabetes mellitus, chronic renal insufficiency (serum creatinine > 2.5 mg/dL), severity of ischemia measured by ABI or toe pressure, wound grade, wound size, and wound location.
Between January 1999 and March 2005, 142 patients with 169 limbs having arterial insufficiency and full-thickness ulceration were treated without revascularization. Mean patient age was 70.8 +/- 4.5. Diabetes mellitus was present in 70.4% of limbs and chronic renal insufficiency in 27.8%. Toe amputations or other foot-sparing procedures were performed in 28% of limbs. Overall, limb loss occurred in 37 patients. By life-table analysis, 19% of limbs required amputation < or =6 months of initial treatment and 23% at 12 months. Complete wound closure was achieved in 25% by 6 months and in 52% by 12 months. Statistical analysis showed a correlation between ABI and the risk of limb loss. In patients with an ABI <0.5, 28% and 34% of limbs experienced limb loss at 6 and 12 months, respectively, compared with 10% and 15% of limbs in patients with an ABI >0.5 (P = .01). The only risk factor associated with wound closure was initial wound size (P < .005).
Limb salvage can be achieved in most patients with arterial insufficiency and uncomplicated chronic nonhealing limb ulcers using a program of wound management without revascularization. Healing proceeds slowly, however, requiring more than a year in many cases. Patients with an ABI <0.5 are more likely to require amputation. Interventions designed to improve outcomes in critical limb ischemia should stratify outcomes based on hemodynamic data and should include a comparative control group given the natural history of ischemic ulcers treated in a dedicated wound program.
人们对受缺血性溃疡影响的肢体的自然病史了解甚少。在本报告中,我们描述了在不适合进行血运重建的患者中,采用伤口愈合技术治疗的伴有稳定慢性腿部溃疡和动脉供血不足的肢体的结局。
使用一个前瞻性维护的综合伤口中心治疗肢体溃疡的数据库,以识别动脉供血不足的患者,动脉供血不足定义为踝肱指数(ABI)<0.7或趾压<50mmHg。当合并症或解剖学因素不允许进行风险可接受的血运重建时,患者在未进行血运重建的情况下接受治疗。溃疡采用强调减压、清创、感染控制和湿性伤口愈合的方案进行治疗。分析对愈合和截肢风险有影响的危险因素包括年龄、性别、糖尿病、慢性肾功能不全(血清肌酐>2.5mg/dL)、通过ABI或趾压测量的缺血严重程度、伤口分级、伤口大小和伤口位置。
1999年1月至2005年3月期间,142例患者的169条肢体存在动脉供血不足和全层溃疡,在未进行血运重建的情况下接受了治疗。患者平均年龄为70.8±4.5岁。70.4%的肢体存在糖尿病,27.8%存在慢性肾功能不全。28%的肢体进行了趾截肢或其他保足手术。总体而言,37例患者出现了肢体缺失。通过寿命表分析,19%的肢体在初始治疗后≤6个月需要截肢,23%在12个月时需要截肢。6个月时25%的伤口实现了完全闭合,12个月时为52%。统计分析显示ABI与肢体缺失风险之间存在相关性。ABI<0.5的患者中,分别有28%和34%的肢体在6个月和12个月时出现肢体缺失,而ABI>0.5的患者中这一比例为10%和15%(P=0.01)。与伤口闭合相关的唯一危险因素是初始伤口大小(P<0.005)。
对于大多数伴有动脉供血不足和无并发症的慢性不愈合肢体溃疡的患者,采用不进行血运重建的伤口管理方案可以实现肢体挽救。然而,愈合过程缓慢,在许多情况下需要一年以上时间。ABI<0.5的患者更有可能需要截肢。旨在改善严重肢体缺血结局的干预措施应根据血流动力学数据对结局进行分层,并且鉴于在专门伤口项目中治疗的缺血性溃疡的自然病史,应包括一个对照比较组。